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Abstract Vaccination with Echinococcus multilocularis
14-3-3 protein can protect mice against primary E. multi-
locularis infection. The present study investigated the
efficacy and efficiency of the adjuvant muramyl dipeptide
Gerbu, alone or together with recombinant 14-3-3 protein,
to modulate the course of secondary E. multilocularis
infection in C56BL/6 mice. The application of Gerbu alone
already resulted in a parasite weight reduction when
compared with infected control mice, while rec14-3-3 did
not add to this effect. Immunological parameters were
concurrently assessed with a mixed cell reaction including
bone marrow-derived dendritic cells (BMDCs) together
with lymph node cells from mice with or without
immunisation and/or infection. While mice having received
Gerbu adjuvant were found to highly proliferate in response
to co-cultivation with 14-3-3-stimulated bone marrow
dendritic cells, a sensitisation of BMDCs with vesicle fluid
(VF) antigen lead to a striking decrease of the lymphopro-
liferative response in comparison to that of control mice,
raising the hypothesis that immunosuppressive components
may be part of this VF-antigen. Anti-14-3-3 antibody
production was only found in those mice that had been
previously 14-3-3-immunised, whereas all other only-infected
mice failed to produce such antibodies. Conclusively, Gerbu
adjuvant appears to directly generate a non-specific immune
response that contributes to the control of the metacestode
growth, putatively in association with a BMDC activity
suppressed by components of the VF-antigen.
Introduction
Secondary experimental infection with Echinococcus multi-
locularis in mice goes along with an intense host–parasite
interplay orchestrated predominantly by the parasite in view
to provide survival (Bresson-Hadni et al. 1990; Emery et al.
1996; Vuitton et al. 1989). The proliferating metacestode of
E. multilocularis consists of an inner, germinal layer,
representing the living parasite, sheathed by an outer
acellular laminated layer providing protection against
effector mechanisms of the host (Gottstein and Hemphill
1997). Protection may also depend on immune-
modulatory effects of parasite metabolites (Gottstein and
Hemphill 1997; Meijri et al. 2010). How this modulation
or evasion is achieved is not yet fully elucidated, either for
Echinococcus granulosus (Diaz et al. 1997) or for E.
multilocularis (Vuitton and Gottstein 2010). Known
parasite molecules of respective relevance include, e.g. a
carbohydrate antigen, Em2(G11), which acts as an T cell-
independent antigen and therefore inhibits maturation of
antibody avidity (Dai et al. 2001). Walker et al. (2004)
found the Em492-antigen, a carbohydrate molecule with
biological activity, supposed to exhibit immuno-
supressive properties at the host–parasite interface. Meta-
cestodic antigens [such as vesicle fluid (VF) from E.
multilocularis] contain substances responsible for the
inactivation of eotaxin by proteolytic activity in vitro.
This inactivation may be relevant for the parasites
survival, as eotaxin works as a main activator and
chemo-attractant for eosinophils, and the impairment of
eosinophils to infiltrate the site of parasite residence seems
to be an important parameter in avoiding the host defense
(Mejri and Gottstein 2009). Similar other studies revealed
that other secreted metacestode products influence the
outcome of an infection in favour of the parasite as well
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(Allen and MacDonald 1998; Lightowlers and Rickard
1988; Pastrana et al. 1998).
In the case of primary (peroral egg) E. multilocularis
infection, first trials had revealed that rec14-3-3 is able to
induce protection in mice against the oncosphere, but not
against a mature larval metacestode (Siles-Lucas et al.
2003). The protective immune response, yielded upon
immunisation with Saponin as adjuvant, was not polarised,
e.g. specific antibodies as well as cytokines accounting for
both Th1 and Th2 orientation were found (Siles-Lucas et al.
2003). In the present study, we addressed the question, how
a more potent adjuvant (Gerbu adjuvant) interacts with the
host immune system, in relation to different types of E.
multilocularis antigens.
Materials and methods
Mice
Female C56/BL6 mice were purchased from Charles River,
Germany. Average age of animals was 8–10 weeks when
mice received the first immunisation. All mice were
handled under standard animal laboratory conditions
according to Swiss regulations for animal experimentation.
Parasite antigens
E. multilocularis VF-antigen was obtained by gentle
disruption of in vitro maintained vesicles, following centrifu-
gation and recovery of supernatant (Ingold et al. 1999). The
protein concentration of the VF batch used in the present
study was 0.94 mg/ml. E. multilocularis rec14-3-3 antigen
was obtained and purified as described before (Dai and
Gottstein 1999; Siles-Lucas et al. 1998), the batch concen-
tration was 0.17 mg protein per millilitre.
Immunisation of C57BL/6 mice and infection with E.
multilocularis metacestodes
For immunisation 10 µg rec14-3-3 were mixed 1:1 with
Gerbu adjuvant (GMDP; Biotechnik GmbH, Gaiberg,
Germany) to yield a final inoculation volume of 100 µl
per injection. Each group of mice (n=5) were subcuta-
neously injected at the shoulder site. A control group
received a mixture of ovalbumin (10 µg per injection, Dr.
Grogg AG) and Gerbu, and another group Gerbu mixed
with an equal volume of phosphate-buffered saline (PBS).
Non-treated control mice received PBS only. Booster
injection ensued 2 weeks later. Another 14 days later,
appropriate groups of mice were infected intra-
peritoneally with E. multilocularis clone KF5as described
before (Dai and Gottstein 1999); the other groups
remained non-infected. Three months post-infection mice
were killed by CO2-euthanasia.
Parasite weighing
The parasite tissue (metacestode mass) was removed
carefully from the peritoneal cavity, freed of any attached
hosts' tissue and weighted.
Cultivation of BMDCs
Naive C56BL/6 animals were killed and bone marrow
progenitors were isolated and cultured as described
elsewhere (Lutz et al. 1999). Culturing took place in
Petri dishes (Greiner, 145/20) with feeding of the cells
every 3 days with 5 ml RPMI 1640 medium (GIBCO
Invitrogen) and 200 U rh GM-CSF (Immunotools,
Friesoythe, Germany). On day 9, non-adherent cells were
harvested and, after counting, adjusted to a concentration
of 1×106 cells per millilitre. Cells were plated in 12-well
plates and supplemented with medium without GM-CSF
for further experiments. Cell preparation contained 75% to
80% CD11c+ bone marrow-derived dendritic cells
(BMDCs) as determined with fluorometric analysis.
Stimulation of immature DCs was carried out as
described below using the following antigens:
– VF (2 µg/ml)
– Rec14-3-3 antigen (1 µg/ml)
– 100 ng/ml lipopolysaccharide (LPS) as a positive control
– Appropriate volume of medium alone as a negative
control
Immature dendritic cells (DCs) were exposed to stimu-
lation with the antigens as described above and maintained
for 16–18 h. Cells were subsequently collected and washed
with warm supplemented medium.
Cell proliferation assay
Lymph node (LN) cells (renal, inguinal, lumbar, and
brachial) from control and treated (immunised with
rec14-3-3, Gerbu, ovabulmin, and PBS and later with
or without E. multilocularis metacestode infection) C56/
BL6 mice were isolated. LN cells (1×106/ml) were co-
cultivated with BMDCs (1×105 /ml) from naive or E.
multilocularis-infected mice. These BMDCs had been
cultured before in medium alone or in medium plus
stimulation with LPS or the three parasite antigens for
18 h and washed thereafter. After 5 days of co-cultivation,
cells were pulsed with 1 µCi/well 3H thymidine. After
18 h, the cells were harvested onto glass fibre filters and
activity measured in a beta counter (PerkinElmer) upon
thymidine incorporation.
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IgG ELISA
Sera of mice were obtained on the day before infection and on
the day of being killed. Sera of day 0 (before vaccination)
served as negative controls, and positive control sera were
used from animals of a previous experiment (Siles-Lucas et al.
1998). The presence of anti-E. multilocularis 14-3-3 and
anti-Em2(G11) [outgroup control antigen] IgG antibodies
was assessed by enzyme-linked immunosorbent assay
(ELISA) as previously described (Dai and Gottstein 1999;
Siles-Lucas et al. 1998). Alkaline phosphatase-conjugated
goat anti-mouse IgG (Promega, Duebendorf, Switzerland),
anti-IgG1, or anti-IgG2a (both from Southern Biotechnology
Associates, Birmingham, USA) was used as second antibody
(conjugate). Absorbance was measured at 405 nm (A405,
reference filter 630 nm) using a Dynatech MR 7000 ELISA
reader and the corresponding Dynatech Biocalc software
(Dynatech, Embrach, Switzerland). The threshold value
arbitrarily discriminating between “positive” and “negative”
(cutoff) was defined by adding three standard deviations to
the mean A405 value of the sera from non-infected and non-
treated control mice.
Results
Parasite weight
The average parasitic mass recovered from PBS-control and
subsequently, from E. multilocularis-infected mice was
1,930 mg (Fig. 1). Rec14-3-3-immunised-and-infected mice
disclosed a significantly lower parasite weight with an
average of 368 mg, as well as mice “control-immunised”
with Gerbu adjuvant only and subsequently infected with E.
multilocularis (average 442 mg; Fig. 1).
Lymphoproliferative responses
The background proliferation activity of LN cells from 14-3-3
immunised mice was slightly elevated after the contact
with immature BMDCs (Fig. 2a), indicating a potential
contamination of the recombinant antigen with bacterial
lipopolysaccharides. Otherwise, all control reactions with
immature BMDCs yielded expected low background
reactivities. LPS-maturated BMDCs originating from all
mouse groups resulted in an elevated LN cell proliferation
when compared with the corresponding activities of
mean parasite weight (mice n=4 per group)
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Fig. 1 Parasite weight recovered from C56BL/6 mice experimentally
infected with E. multilocularis. Mice were either mock-immunised
with PBS only or received Gerbu adjuvant supported immunisation
with or without rec14-3-3-antigen. Horizontally labelled bars indicate
p values for statistical significances
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Fig. 2 Mixed BMDCs–lymphoproliferative assays. BMDCs were
initially either kept with medium alone (immature DCs, iDCs) (a), or
challenged for 16–18 h with LPS (b), VF (c), or rec14-3-3 (d), all
iDCs were subsequently co-cultured with LN cells isolated from the
following mouse groups: non-immunised/non-infected mice (naive
Ctrl mice); E. multilocularis-infected mice: initially treated with PBS
as a control (PBS-inf.), Gerbu-alone (Gerbu-inf.), ovabulmin plus
Gerbu- (Ova-imm-inf.), or 14-3-3-plus Gerbu (14-3-3-imm-inf). Mice
were killed 3 months after infection, control mice also on the same
day. Incorporation of tritium-labelled thymidine was expressed as
counts per minute (cpm). Statistical significances are labelled with an
* and were at p<0.05
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immature DCs (Fig. 2b). The highest reaction to LPS-
maturated DCs was again seen in the 14-3-3 LN cells. VF-
presentation by BMDCs resulted in high proliferative
activity of only LN cells from naive mice (significantly
higher to all other groups), whereas all other mouse
groups exhibited only moderate to low proliferative
responses (Fig. 2c). BMDCs stimulated with 14-3-3
resulted in a high proliferative response of LN cells from
all three immunised-and-infected mice (all co-exposed to
the Gerbu adjuvant). Conversely, LN cells from non-
infected control animals and PBS-control-and-infected
mice demonstrated an only very moderate response.
IgG ELISA
Serological analyses were carried out after 14-3-3-immuni-
sation and later after immunisation plus 3 months of
infection. ELISA was used to determine anti-14-3-3 IgG
antibodies and antibodies to an outgroup control antigen
[Em2(G11)]. Mice immunised with rec14-3-3 without or
not yet infected showed no antibody production to control
Em2(G11)-antigen, while 14-3-3-immunised mice, as
expected, presented a marked anti-14-3-3-specific antibody
reactivity (Fig. 3b). All infected mice revealed a marked
anti-Em2(G11) antibody response, while anti-rec14-3-3
antibodies were only detectable in mice previously immu-
nised with 14-3-3 (Fig. 3a), thus demonstrating that
intraperitoneal E. multilocularis infection alone does not
yield an anti-14-3-3-antibody production.
Discussion
Former studies (Reuben and Tanner 1983; Siles-Lucas et al.
2003) provided evidence of distinct differences between the
initial anti-oncospheral immune response and the subsequent
immune response directed against an established, maturated
and fully active metacestode of E. multilocularis. Siles-Lucas
et al. (2003) also showed that vaccination with rec14-3-3
yielded a good protection against primary E. multilocularis
infection (peroral egg infection), while this immunity was
ineffective against secondary infection (intraperitoneal inoc-
ulation of mature metacestodes). The interplay between a
mature metacestode (chronic stage of infection/disease) and
its murine host was intensively studied by multiple research
groups (reviewed, e.g. by Gottstein and Hemphill 2008; Mejri
and Gottstein 2009; Vuitton 2003) and had provided insight
into the mode the parasite is involved in the modulation of
the host immunity. The question we now presently addressed
was if 14-3-3, though not inducing protection in mice
secondarily infected with the metacestode, influences never-
theless the immune response thus as to yield a different
immune recognition pattern when compared with non-
immunised animals. During our first experiments, we
Fig. 3 ELISA-based analyses of serological antibody reactivities
against rec14-3-3-antigen or against an outgroup control antigen Em2
(G11). a immunised-and-infected mice, b mice only immunised.
Positive and negative control sera are labelled as NegCon and
PosCon, respectively. PBS-group: mice receiving a mock-
immunisation with PBS alone; Gerbu-group: mice receiving Gerbu
adjuvant without antigen; Ova-group: mice immunised with Gerbu
and ovalbumin; 14-3-3-group: mice immunised with Gerbu and rec14-
3-3-antigen
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replaced the formerly used adjuvant saponin (Siles-Lucas et
al. 2003) with the synthetic immunoadjuvant Gerbu. Gerbu
is a muramyl dipeptide (MDP) representing the smallest
subunit of bacterial cell walls still active as an adjuvant
(Adam and Lederer 1984). Gerbu originates from Gram-
positive cell walls and displays a good alternative to
common adjuvants, as it can be injected directly and safely
in vivo. Conversely to saponin, immunisation with Gerbu
and subsequent secondary infection yielded in a reduction of
metacestode growth when being compared with non-
immunised alveolar echinococcosis (AE)-infected mice. This
effect was independent of an additional use of antigen such
as rec14-3-3 that we employed in the present study. At the
early beginning of immunological E. multilocularis research,
Reuben et al. (1978) had already revealed that the use of
Bacillus Calmette-Guérin (BCG) (originating from an
attenuated Mycobacterium bovis strain and inducing variable
protection against tuberculosis and cancer) and also its cell
wall skeleton (CWS) were inducing protection in cotton rats
against the metacestode stage of infection. The use of
lipoprotein from Mycobacterium tuberculosis is known to
induce an effective Th1 cell-mediated immune response by
TLR2 activation (Thoma-Uszynski et al. 2001), and so
protection may be associated with the induction of a proper
Th1 response. The former findings upon use of BCG or
BCG-CWS had revealed a dose-dependent degree of
protection; a low dose was not effective while a too-high
dose formed tubercular granulomas in the host. So far, we
have not addressed a dose-dependence of the Gerbu-effect in
experimental murine AE. So far, most groups agreed that
secondary murine AE includes a mixed Th1/Th2 response,
so the working hypothesis discussed by several authors was
that partial protection (=reduced metacestode proliferation)
may be associated with a rather Th1-orientation of immune
response. ATh2-orientation may be in favour of metacestode
proliferation (Amiot et al. 1999; Emery et al. 1996; Godot et
al. 2003; Jenne et al. 1998; Liance et al. 1998).
The results showing reduced parasite masses in both
Gerbu and Gerbu-rec14-3-3 immunised mice are in con-
gruence with those of the lymphocyte proliferation assays.
We found that stimulation of BMDCs cultivated with
rec14-3-3 protein of E. multilocularis, and the following
combination of these cells with LN cells from Gerbu-
treated mice resulted in antigen recognition and so to a
significant LN cell proliferation. Conversely, non-Gerbu-
treated groups showed no reactivity to 14-3-3 stimulation.
This raises the question whether this adjuvant does
somehow interfere with the parasite or the mode the
parasite exerts immune modulation of the host. Investiga-
tion of the humoral immune response also provided data as
expected. First, sera obtained after rec14-3-3-immunisation
showed the presence and thus proved synthesis of anti-
rec14-3-3 IgGs, whereas no antibodies against the outgroup
control antigen Em2(G11) were yet detectable. Anti-Em2
(G11) IgG levels were positive in the sera of all immunised-
and-infected or only-infected mice, while naive (non-infected
control) mice produced no anti-Em2(G11) antibodies, as
expected. Immuno-stimulating activity of vaccine adjuvants,
such as muramyl dipeptides, may not only orchestrate the
mode of antigen delivery to immunological sites, but may also
influence the induction of secondary signals like B-7 family
receptors and CD40 on APCs, directly or indirectly (Schijns
2000). This will be the focus of forthcoming studies we will
carry out on the expression of co-stimulatory molecules
compared between BMDCs from naive versus infected mice
after different stimulations. MDP and derivates are strong
inducers of a variety of cytokines such as IL-1, IL-6, TNFα,
and IFN-γ in mice and humans and are therefore activating
different cell types including Th1, Th2, or Th17 (de Jong et
al. 2010). Another point of investigation we plan to
undertake is to analyse the cytokine production pattern of
cultured BMDCs stimulated in vitro with Gerbu adjuvant.
The recognition of rec14-3-3 by LN cells from Gerbu-treated
mice may be induced by unblocking of certain receptors. An
interesting presumption by Rock et al. (1998) is that
mycobacterial adjuvants do serve as ligands for receptors
on immune competent cells, inducing marked cellular
responses. At an early beginning of AE infection, the
parasite is assumed to already start its modulation of the
hosts' immune response such as to allow its subsequent
survival. The accompanying innate immune system, largely
non-specific and constitutively expressing pathogen recogni-
tion receptors for the recognition of pathogen-associated
microbial patterns (PAMPs), may also be involved in the
subsequent modulation of the specific immune response
(Gerard et al. 1998). In vivo, E. multilocularis is expressing
the carboxylated protein 14-3-3 in its germinal layer. In our
present study, however, this antigen was presented by
respectively in vitro-stimulated BMDCs such as to induce a
subsequent lymphocyte proliferation. BCG is known to
activate multiple Toll-like receptors (TLR; Azuma and Seya
2001); Gerbu also may function as a ligand for TLRs,
interfering in the parasites reaction by uncovering different
TLRs, so putatively miscasting the parasites modulation
efficacy and thus proliferation (growth) efficiency. In a
similar context, several authors (Azuma and Seya 2001)
favoured a hypothesis in which TLR receptors may induce
cellular responses supported by similar signaling events. The
lack of TLR ligation/activation was supposed to initiate a
Th2-oriented humoral immune response, which in E. multi-
locularis-infected man and mice may—at least partially—
account for the AE-specific (mixed Th1/Th2) immune
orientation. Several MDP derivates also revealed the ability
of re-stimulating immuno-suppressed mice, rats, and guinea
pigs (Osada et al. 1982). A variety of TLRs were found to be
expressed on DCs (Rock et al. 1998), allowing DCs to
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recognise PAMPs, like LPS. Furthermore, a large panel of
TLRs is expressed on DC surfaces, like TLR-2, which is
generally thought to be the receptor for Gram-positive
bacteria (Knapp et al. 2002). In view of future experiments,
we may address the different steps that account for Gerbu or
other adjuvants to influence the activation status of DCs
from naïve or AE-infected mice. Schijns (2000) had already
proposed that, beside several signals which are important for
DC activation, along with antigen presentation and the
delivery of co-stimulatory molecules and cytokines, adju-
vants may act as an induction factor, too. Another aspect to
study as a result from our findings is that of putative
therapeutic effects of amphotericin B and other antibiotics,
which showed synergistic effects in combination with MDP
derivates (Rock et al. 1998). As treatment with amphotericin
B already showed a reduction in vesicle proliferation in vitro
(Reuter et al. 2003), a promising approach could arise from
enhancing the treatment efficacy by co-stimulation with an
appropriate adjuvant.
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